Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Akopov, V. Egorov, G. Nikolaev (St Petersburg, Russia). The role of surgery in cytologically positive pleural effusion in NSCLC. Eur Respir J 2003; 22: Suppl. 45, 1446

Member's Comments

No comment yet.

Related content which might interest you: The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 542s Year: 2003 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 The role of thoracoscopy in the diagnosis of malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002 Pleural effusion in cases of breast carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Prognosis of patients with NSCLC undergoing positive pleural lavage cytology Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009 Diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules Year: 2007 Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011 Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung? Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007 The value of thoracoscopy in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 516s Year: 2001